Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Meta-analysis of type-specific HPV DNA prevalence in invasive cervical cancer [15], updated with 63 newly published studies by Clifford (IARC)

From: Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

  N tested N pos % pos 95% CI
hpv39 13370 172 1.29 1.10 – 1.48
hpv59 13471 172 1.28 1.09 – 1.47
hpv51 13057 151 1.16 0.97 – 1.34
hpv56 13247 103 0.78 0.63 – 0.93
hpv68 11982 73 0.61 0.47 – 0.75
hpv73 9939 48 0.48 0.35 – 0.62
hpv6 14912 68 0.45 0.35 – 0.56
hpv53 8140 34 0.42 0.28 – 0.56
hpv66 12118 47 0.39 0.28 – 0.50
hpv70 10503 35 0.33 0.22 – 0.44
hpv82 9265 25 0.27 0.16 – 0.38
hpv26 6111 8 0.13 0.04 – 0.22
  1. HPV types 30, 34, 67, 85 and 97 were not studied in the meta-analysis dataset.